학술논문
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
Document Type
Article
Author
Traussnigg, S.; Halilbasic, E.; Trauner, M.; Schattenberg, J.M.; Demir, M.; Wiegand, J.; Geier, A.; Teuber, G.; Hofmann, W.P.; Kremer, A.E.; Spreda, F.; Kluwe, J.; Petersen, J.; Boettler, T.; Rainer, F.; Fickert, P.; Greinwald, R.; Pröls, M.; Manns, M.P.; Vogel, W.; Aigner, E.; Datz, C.; Tilg, H.; Gerken, G.; Rust, C.; Cordes, H.-J.; Steib, C.; Pathil-Warth, A.; Prinz, MD, C.; Lammert, F.; Antoni, C.; Klausmann, G.; Häussinger, D.; Zipprich, A.
Source
In: The Lancet Gastroenterology and Hepatology . (The Lancet Gastroenterology and Hepatology, October 2019, 4(10):781-793)
Subject
Language
English
ISSN
24681253